Catalent to buy supplement maker Bettera Holdings in $1B deal
Over the current book year the total revenu from the company based in Somerset will be 4.48 billion USD (consensus estimates). This is rather significant more than 2021's revenue of 4 billion USD.
Historical revenues and results Catalent Inc. plus estimates 2021
The analysts expect for 2021 a net profit of 657 million USD. For this year most of the analysts expect a profit per share of 3.52 USD. The price-earnings-ratio equals 39.66.
For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals a relatively high 2.64 percent.
Catalent Inc.'s market capitalization is based on the number of outstanding shares around 22.73 billion USD. 62
At 18.08 the stock trades 0.06 percent higher at 139.6 USD.Price data Catalent Inc. 2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
